Abridge Inc
PrivateLast Round
Series E
6/24/2025
Est. Valuation
$5.3B
Total Funding Raised
$747.5M
Momentum Score
25 /100
Company Overview
Abridge is a healthcare technology company that offers an audio-based application utilizing machine learning to record and summarize medical conversations, providing users with context and clarity to better follow their doctors' recommendations.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Vertical SaaS, Workflow Automation, EHR & EMR
Business Model
B2B
Customer Profile
Subscription SaaS, Government Contracts, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abridge Inc Comps
Public and private peers based on sector, stage, and business model.
Abridge Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | 6/24/2025 | ||||
| Series D | 2/17/2025 | ||||
| Series C | 2/23/2024 | ||||
| Series B | 10/26/2023 | ||||
| Series A Extension | 8/11/2022 | ||||
Seed | 10/6/2020 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID | |||||
BID |
Key People
Founding team and executive leadership
Abridge Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series E |
| SV Angel | Series D |
| California Health Care Foundation | Series D |
| Aetna Ventures | Series B |
| Union Square Ventures | Series C, Series A Extension, Series B, Seed |
| Kaiser Permanente Ventures | Series B, Series C |
| Khosla Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
HonorHealth selected ambient AI solution for 500 clinicians.
- Apr 15, 2026
Partnered with the American Medical Association, publisher of JAMA Network.
Abridge Inc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abridge Inc's valuation, stock price, and market status.
